XML 104 R91.htm IDEA: XBRL DOCUMENT v3.19.1
SEGMENT INFORMATION - Disaggregation of Revenue (Details)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2018
product
Disaggregation of Revenue [Line Items]      
Revenues $ 2,016 $ 1,995  
Number of products represented of total revenue | product     10
Revenues | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk percentage 36.00% 35.00%  
Pharmaceuticals      
Disaggregation of Revenue [Line Items]      
Revenues $ 968 $ 966  
Devices      
Disaggregation of Revenue [Line Items]      
Revenues 404 392  
OTC      
Disaggregation of Revenue [Line Items]      
Revenues 324 326  
Branded and Other Generics      
Disaggregation of Revenue [Line Items]      
Revenues 293 281  
Other revenues      
Disaggregation of Revenue [Line Items]      
Revenues 27 30  
Bausch Lomb/ International      
Disaggregation of Revenue [Line Items]      
Revenues 1,118 1,103  
Bausch Lomb/ International | Pharmaceuticals      
Disaggregation of Revenue [Line Items]      
Revenues 217 203  
Bausch Lomb/ International | Devices      
Disaggregation of Revenue [Line Items]      
Revenues 366 363  
Bausch Lomb/ International | OTC      
Disaggregation of Revenue [Line Items]      
Revenues 324 326  
Bausch Lomb/ International | Branded and Other Generics      
Disaggregation of Revenue [Line Items]      
Revenues 191 191  
Bausch Lomb/ International | Other revenues      
Disaggregation of Revenue [Line Items]      
Revenues 20 20  
Salix      
Disaggregation of Revenue [Line Items]      
Revenues 445 422  
Salix | Pharmaceuticals      
Disaggregation of Revenue [Line Items]      
Revenues 445 422  
Salix | Devices      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Salix | OTC      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Salix | Branded and Other Generics      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Salix | Other revenues      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Ortho Dermatologics      
Disaggregation of Revenue [Line Items]      
Revenues 138 140  
Ortho Dermatologics | Pharmaceuticals      
Disaggregation of Revenue [Line Items]      
Revenues 95 105  
Ortho Dermatologics | Devices      
Disaggregation of Revenue [Line Items]      
Revenues 38 29  
Ortho Dermatologics | OTC      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Ortho Dermatologics | Branded and Other Generics      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Ortho Dermatologics | Other revenues      
Disaggregation of Revenue [Line Items]      
Revenues 5 6  
Diversified Products      
Disaggregation of Revenue [Line Items]      
Revenues 315 330  
Diversified Products | Pharmaceuticals      
Disaggregation of Revenue [Line Items]      
Revenues 211 236  
Diversified Products | Devices      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Diversified Products | OTC      
Disaggregation of Revenue [Line Items]      
Revenues 0 0  
Diversified Products | Branded and Other Generics      
Disaggregation of Revenue [Line Items]      
Revenues 102 90  
Diversified Products | Other revenues      
Disaggregation of Revenue [Line Items]      
Revenues $ 2 $ 4